Academic Integrity: tutoring, explanations, and feedback — we don’t complete graded work or submit on a student’s behalf.

Comparison of mortality rates due to cancer of the uterus in users and non-users

ID: 3323572 • Letter: C

Question

Comparison of mortality rates due to cancer of the uterus in users and non-users of supplemental estrogen revealed:

Mortality rates per 100,000


Age in years


45-54

55-70

Users of estrogen

3.0

17.0

Non-users of estrogen

1.0

6.0

A valid conclusion derived from the above data concerning the association of estrogen use with mortality due to uterine cancer is:

A. Among women 45-54 years of age, those who use estrogen are 2.83 times as likely to die from uterine cancer compared with those who do not use estrogen.

B. Among women 55-70 years of age, those who use estrogen are 2.83 times as likely to die from uterine cancer compared with those who do not use estrogen.

C. Among women 55-70 years of age, those who use estrogen are 3.0 times as likely to die from uterine cancer compared with those who do not use estrogen.

D. Among women 55-70 years of age, those who use estrogen are 0.35 times as likely to die from uterine cancer compared with those who do not use estrogen.

E. None of the above

Mortality rates per 100,000


Age in years


45-54

55-70

Users of estrogen

3.0

17.0

Non-users of estrogen

1.0

6.0

Explanation / Answer

Solution : Option ( B )= Among women 55-70 years of age, those who use estrogen are 2.83 times as likely to die from uterine cancer compared with those who do not use estrogen.

likelyness of dying from uterus cancer of women who use estrogen compared to women who do not use  

estrogen among 45 - 54 years of age = 3.0 / 1.0 = 3

likelyness of dying from uterus cancer of women who use estrogen compared to women who do not use  

  estrogen among 55 - 70 years of age = 17.0 / 6.0 = 2.8333

Hire Me For All Your Tutoring Needs
Integrity-first tutoring: clear explanations, guidance, and feedback.
Drop an Email at
drjack9650@gmail.com
Chat Now And Get Quote